Optic neuropathies: Characteristic features and mechanisms of retinal ganglion cell loss

Reviews in the Neurosciences

Volumn 24, Issue 3, 2013, Pages 301-321

  You, Yuyi ^a   Gupta, Vivek K ^a   Li, Jonathan C ^a   Klistorner, Alexander ^a,b   Graham, Stuart L ^a,b  

^a MACQUARIE UNIVERSITY   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Electrophysiology; Glaucoma; Neuroprotection; Optic nerve; Optic neuritis; Optic neuropathy; Retinal ganglion cell

Indexed keywords

7,8 DIHYDROXYFLAVONE; BRAIN DERIVED NEUROTROPHIC FACTOR; CILIARY NEUROTROPHIC FACTOR; CORTICOSTEROID; FINGOLIMOD; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; NERVE GROWTH FACTOR; NEUROTROPHIN 3; NEUROTROPHIN 4;

ALLERGIC ENCEPHALOMYELITIS; ARTICLE; CELL LOSS; CELL SURVIVAL; CLINICAL FEATURE; COMPARATIVE ANATOMY; DARK ADAPTATION; ELECTRORETINOGRAM; ELECTROSTIMULATION THERAPY; ENZYME INDUCTION; EVOKED VISUAL RESPONSE; EXCITOTOXICITY; GLAUCOMA; HEREDITARY OPTIC ATROPHY; HUMAN; ISCHEMIC OPTIC NEUROPATHY; MICROVASCULARIZATION; MULTIPLE SCLEROSIS; MYELINATION; NERVE PROJECTION; NERVE SHEATH; NEUROPROTECTION; NONHUMAN; OPTIC NERVE DISEASE; OPTIC NERVE FIBER; OPTIC NERVE LESION; OPTIC NEURITIS; PRIORITY JOURNAL; RETINA GANGLION CELL; SIGNAL TRANSDUCTION; VISUAL THRESHOLD; ANIMAL; APOPTOSIS; METABOLISM; NERVE FIBER; OPTIC NERVE; PATHOLOGY; REVIEW; ULTRASTRUCTURE;

ANIMALS; APOPTOSIS; AXONS; EVOKED POTENTIALS, VISUAL; HUMANS; OPTIC NERVE; OPTIC NERVE DISEASES; RETINAL GANGLION CELLS;

EID: 84877949183     PISSN: 03341763     EISSN: None     Source Type: Journal    
DOI: 10.1515/revneuro-2013-0003     Document Type: Article

References (247)

1. Agarwal, N., Agarwal, R., Kumar, D.M., Ondricek, A., Clark, A.F., Wordinger, R.J., and Pang, I.H. (2007). Comparison of expression profile of neurotrophins and their receptors in primary and transformed rat retinal ganglion cells. Mol. Vis. 13, 1311-1318.
2. Allen, C.M.C., Lueck, C.J., and Dennis, M. (2010). Neurological disease. Davidson's Principles and Practice of Medicine 21st edn. N.R. Colledge, B.R. Walker, and S.H. Ralston, eds. (Edinburgh: Elsevier), pp. 1131-1235.
3. Almasieh, M., Wilson, A.M., Morquette, B., Cueva Vargas, J.L., and Di Polo, A. (2012). The molecular basis of retinal ganglion cell death in glaucoma. Prog. Retin. Eye Res. 31, 152-181.
4. Alward, W.L. (1998). Medical management of glaucoma. N. Engl. J. Med. 339, 1298-1307.
5. Arieli, A., Sterkin, A., Grinvald, A., and Aertsen A. (1996). Dynamics of ongoing activity: Explanation of the large variability in evoked cortical potentials. Science 273, 1868-1871.
6. Asgari, N., Owens, T., Frøkiær, J., Stenager, E., Lillevang, S.T., and Kyvik, K.O. (2011). Neuromyelitis optica (NMO) - an autoimmune disease of the central nervous system (CNS). Acta Neurol. Scand. 123, 369-384.
7. Atilla, H., Tekeli, O., Örnek, K., Batioglu, F., Halil Elhan, A., and Eryilmaz, T. (2006). Pattern electroretinography and visual evoked potentials in optic nerve diseases. J. Clin. Neurosci. 13, 55-59.
8. Atkins, E.J., Bruce, B.B., Newman, N.J., and Biousse, V. (2010). Treatment of nonarteritic anterior ischemic optic neuropathy. Surv. Ophthalmol. 55, 47-63.
9. Bach, M. and Hoffmann, M.B. (2006). The Origin of the Pattern Electroretinogram. Principles and Practice of Clinical Electrophysiology of Vision. 2nd edn. J.R. Heckenlively and G.B. Arden, eds. (Cambridge, MA: MIT Press), pp. 185-196.
10. Bai, Y., Xu, J., Brahimi, F., Zhuo, Y., Sarunic, M.V., and Saragovi, H.U. (2010a). An agonistic TrkB mAb causes sustained TrkB activation, delays RGC death, and protects the retinal structure in optic nerve axotomy and in glaucoma. Invest. Ophthalmol. Vis. Sci. 51, 4722-4731.
11. Bai, Y., Dergham, P., Nedev, H., Xu, J., Galan, A., Rivera, J.C., ZhiHua, S., Mehta, H.M., Woo, S.B., Sarunic, M.V., et al. (2010b). Chronic and acute models of retinal neurodegeneration TrkA activity are neuroprotective whereas p75NTR activity is neurotoxic through a paracrine mechanism. J. Biol. Chem. 285, 39392- 39400.
12. Bakalash, S., Kipnis, J., Yoles, E., and Schwartz, M. (2002). Resistance of retinal ganglion cells to an increase in intraocular pressure is immune-dependent. Invest. Ophthalmol. Vis. Sci. 43, 2648-2653.
13. Balcer, L.J. (2006). Optic neuritis. N. Eng. J. Med. 354, 1273-1280.
14. Baltan, S., Besancon, E.F., Mbow, B., Ye, Z., Hamner, M.A., and Ransom, B.R. (2008). White matter vulnerability to ischemic injury increases with age because of enhanced excitotoxicity. J. Neurosci. 28, 1479-1489.
15. Beck, R.W., Cleary, P.A., Anderson, M.M. Jr., Keltner, J.L., Shults, W.T., Kaufman, D.I., Buckley, E.G., Corbett, J.J., Kupersmith, M.J., Miller, N.R., et al. (1992). A randomized, controlled trial of corticosteroids in the treatment of acute optic neuritis. The Optic Neuritis Study Group. N. Engl. J. Med. 326, 581-588.
16. Beck, R.W., Trobe, J.D., and Moke, P.S. (2003). High- and low-risk profiles for the development of multiple sclerosis within 10 years after optic neuritis: Experience of the optic neuritis treatment trial. Arch. Ophthalmol. 121, 944-949.
17. Benn, S.C. and Woolf, C.J. (2004). Adult neuron survival strategies - slamming on the brakes. Nat. Rev. Neurosci. 5, 686-700.
18. Berdahl, J.P., Allingham, R.R., and Johnson, D.H. (2008). Cerebrospinal fluid pressure is decreased in primary open-angle glaucoma. Ophthalmology 115, 763-768.
19. Beretta, S., Mattavelli, L., Sala, G., Tremolizzo, L., Schapira, A.H., Martinuzzi, A., Carelli, V., and Ferrarese, C. (2004). Leber hereditary optic neuropathy mtDNA mutations disrupt glutamate transport in cybrid cell lines. Brain 127 (Pt 10), 2183-2192.
20. Bernstein, S.L., Guo, Y., Kelman, S.E., Flower, R.W., and Johnson, M.A. (2003). Functional and cellular responses in a novel rodent model of anterior ischemic optic neuropathy. Invest. Ophthalmol. Vis. Sci. 44, 4153-4162.
21. Bernstein, S.L., Johnson, M.A., and Miller, N.R. (2011). Nonarteritic anterior ischemic optic neuropathy (NAION) and its experimental models. Prog. Retin. Eye Res. 30, 167-187.
22. Bettelli, E., Pagany, M., Weiner, H.L., Linington, C., Sobel, R.A., and Kuchroo, V.K. (2003). Myelin oligodendrocyte glycoprotein-specific T cell receptor transgenic mice develop spontaneous autoimmune optic neuritis. J. Exp. Med. 197, 1073-1081.
23. Blakemore, W.F. and Franklin, R.J.M. (2008). Remyelination in Experimental Models of Toxin-Induced Demyelination. Current Topics in Microbiology and Immunology. Advances in Multiple Sclerosis and Experimental Demyelinating Diseases. M. Rodriguez, ed. (Berlin, Heidelberg: Springer), pp. 193-212.
24. Bonfanti, L., Strettoi, E., Chierzi, S., Cenni, M.C., Liu, X.H., Martinou, J.-C., Maffei, L., and Rabacchi, S.A. (1996). Protection of retinal ganglion cells from natural and axotomy-induced cell death in neonatal transgenic mice overexpressing bcl-2. J. Neurosci. 16, 4186-4194.
25. Bose, S., Dhillon, N., Ross-Cisneros, F.N., and Carelli, V. (2005). Relative post-mortem sparing of afferent pupil fibers in a patient with 3460 Leber's hereditary optic neuropathy. Graefes. Arch. Clin. Exp. Ophthalmol. 243, 1175-1179.
26. Boucard, C.C., Hernowo, A.T., Maguire, R.P., Jansonius, N.M., Roerdink, J.B.T.M., Hooymans, J.M.M., and Cornelissen, F.W. (2009). Changes in cortical grey matter density associated with long-standing retinal visual field defects. Brain 132 (Pt 7), 1898-1906.
27. Brady, S.T., Witt, A.S., Kirkpatrick, L.L., de Waegh, S.M., Readhead, C., Tu, P.H., and Lee, V.M. (1999). Formation of compact myelin is required for maturation of the axonal cytoskeleton. J. Neurosci. 19, 7278-7288.
28. Brown, M.D., Trounce, I.A., Jun, A.S., Allen, J.C., and Wallace, D.C. (2000). Functional analysis of lymphoblast and cybrid mitochondria containing the 3460, 11778, or 14484 Leber's hereditary optic neuropathy mitochondrial DNA mutation. J. Biol. Chem. 275, 39831-39836.
29. Bruck, W. (2005). Inflammatory demyelination is not central to the pathogenesis of multiple sclerosis. J. Neurol. 252 Suppl 5, v10-v15.
30. Brundin, P., Li, J.Y., Holton, J.L., Lindvall, O., and Revesz, T. (2008). Research in motion: The enigma of Parkinson's disease pathology spread. Nat. Rev. Neurosci. 9, 741-745.
31. Buchi, E.R. (1992). Cell death in the rat retina after a pressureinduced ischaemia-reperfusion insult: An electron microscopic study. I. Ganglion cell layer and inner nuclear layer. Exp. Eye. Res. 55, 605-613.
32. Bui, B.V. and Fortune, B. (2003). Ganglion cell contributions to the rat full-field electroretinogram. J. Physiol. 555, 153-173.
33. Bui, B.V. and Fortune, B. (2004). Ganglion cell contributions to the rat full-field electroretinogram. J. Physiol. 555 (Pt 1), 153-173.
34. Bull, N.D. and Martin, K.R. (2011). Concise review: Toward stem cell-based therapies for retinal neurodegenerative diseases. Stem Cells 29, 1170-1175.
35. Bull, N.D., Irvine, K.A., Franklin, R.J., and Martin, K.R. (2009). Transplanted oligodendrocyte precursor cells reduce neurodegeneration in a model of glaucoma. Invest. Ophthalmol. Vis. Sci. 50, 4244-4253.
36. Canteras, N.S., Ribeiro-Barbosa, E.R., Goto, M., Cipolla-Neto, J., and Swanson, L.W. (2011). The retinohypothalamic tract: Comparison of axonal projection patterns from four major targets. Brain Res. Rev. 65, 150-183.
37. Carrasco, J.R. and Penne, R.B. (2004). Optic nerve sheath meningiomas and advanced treatment options. Curr. Opin. Ophthalmol. 15, 406-410.
38. Carroll, W.M., Jennings, A.R., and Ironside, L.J. (1998). Identification of the adult resting progenitor cell by autoradiographic tracking of oligodendrocyte precursors in experimental CNS demyelination. Brain 121, 293-302.
39. Cenni, M.C., Bonfanti, L., Martinou, J.C., Ratto, G.M., Strettoi, E., and Maffei, L. (1996). Long-term survival of retinal ganglion cells following optic nerve section in adult bcl-2 transgenic mice. Eur. J. Neurosci. 8, 1735-1745.
40. Chao, M.V. (2003). Neurotrophins and their receptors: A convergence point for many signalling pathways. Nat. Rev. Neurosci. 4, 299-309.
41. Chao, M.V. and Bothwell, M. (2002). Neurotrophins - to cleave or not to cleave. Neuron 33, 9-12.
42. Chaudhary, P., Ahmed, F., Quebada, P., and Sharma, S.C. (1999). Caspase inhibitors block the retinal ganglion cell death following optic nerve transection. Brain Res. Mol. Brain Res. 67, 36-45.
43. Chen, H. and Weber, A.J. (2001). BDNF enhances retinal ganglion cell survival in cats with optic nerve damage. Invest. Ophthalmol. Vis. Sci. 42, 966-974.
44. Chen, C.S., Johnson, M.A., Flower, R.A., Slater, B.J., Miller, N.R., and Bernstein, S.L. (2008). A primate model of nonarteritic anterior ischemic optic neuropathy. Invest. Ophthalmol. Vis. Sci. 49, 2985-2992.
45. Chen, H., Wei, X., Cho, K.S., Chen, G., Sappington, R., Calkins, D.J., and Chen, D.F. (2011). Optic neuropathy due to microbeadinduced elevated intraocular pressure in the mouse. Invest Ophthalmol Vis. Sci. 52, 36-44.
46. Cheng, L., Sapieha, P., Kittlerová, P., Hauswirth, W.W., and Di Polo, A. (2002). TrkB gene transfer protects retinal ganglion cells from axotomy-induced death in vivo. J. Neurosci. 22, 3977-3986.
47. Cheung, Z.H., Gong, K., and Ip, N.Y. (2008). Cyclin-dependent kinase 5 supports neuronal survival through phosphorylation of Bcl-2'. J. Neurosci. 28, 4872-4877.
48. Conti, A.C., Raghupathi, R., Trojanowski, J.Q., and McIntosh, T.K. (1998). Experimental brain injury induces regionally distinct apoptosis during the acute and delayed post-traumatic period. J. Neurosci. 18, 5663-5672.
49. Cordeiro, M.F., Guo, L., Luong, V., Harding, G., Wang, W., Jones, H.E., Moss, S.E., Sillito, A.M., and Fitzke, F.W. (2004). Real-time imaging of single nerve cell apoptosis in retinal neurodegeneration. Proc. Natl. Acad. Sci. USA 101, 13352-13356.
50. Cursiefen, C., Korth, M., and Horn, F.K. (2001). The negative response of the flash electroretinogram in glaucoma. Documenta Ophthalmologica 103, 1-12.
51. Dahlmann-Noor, A.H., Vijay, S., Limb, G.A., and Khaw, P.T. (2010). Strategies for optic nerve rescue and regeneration in glaucoma and other optic neuropathies. Drug Discov. Today 15, 287-299.
52. de Calignon, A., Polydoro, M., Suárez-Calvet, M., William, C., Adamowicz, D.H., Kopeikina, K.J., Pitstick, R., Sahara, N., Ashe, K.H., Carlson, G.A., et al. (2012). Propagation of tau pathology in a model of early Alzheimer's disease. Neuron 73, 685-697.
53. DelMonte, D.W. and Bhatti, M.T. (2009). Ischemic optic neuropathy. Int. Ophthalmol. Clin. 49, 35-62.
54. Dickersin, K., Manheimer, E., and Li, T. (2012). Surgery for nonarteritic anterior ischemic optic neuropathy. Cochrane Database Syst. Rev. CD001538 (1).
55. Dong, C.J., Guo, Y., Agey, P., Wheeler, L., and Hare, W.A. (2008). Alpha2 adrenergic modulation of NMDA receptor function as a major mechanism of RGC protection in experimental glaucoma and retinal excitotoxicity. Invest. Ophthalmol. Vis. Sci. 49, 4515-4522.
56. Drasdo, N., Aldebasi, Y.H., Chiti, Z., Mortlock, K.E., Morgan, J.E., and North, R.V. (2001). The S-Cone PhNR and pattern ERG in primary open angle glaucoma. Invest. Ophthalmol. Vis. Sci. 42, 1266-1272.
57. Du, J.L. and Poo, M.M. (2004). Rapid BDNF-induced retrograde synaptic modification in a developing retinotectal system. Nature 429, 878-883.
58. Fahle, M. and Bach, M. (2006). Origin of the Visual Evoked Potentials. Principles and Practice of Clinical Electrophysiology of Vision. 2nd edn. J. Heckenlively and G. Arden, eds. (Cambridge, MA: MIT Press), pp. 207-234.
59. Fan, T.J., Han, L.H., Cong, R.S., and Liang, J. (2005). Caspase family proteases and apoptosis. Acta Biochimica et Biophysica Sinica 37, 719-727.
60. Fazio, D.T., Heckenlively, J.R., Martin, D.A., and Christensen, R.E. (1986). The electroretinogram in advanced open-angle glaucoma. Doc. Ophthalmol. 63, 45-54.
61. Feinsod, M. and Auerbach, E. (1969). Changes in the electroretinogram (ERG) in lesions of the optic nerve. Electroencephalogr. Clin. Neurophysiol. 27, 217.
62. Ferguson, B., Matyszak, M.K., Esiri, M.M., and Perry, V.H. (1997). Axonal damage in acute multiple sclerosis lesions. Brain 120, 393-399.
63. Flammer, J. and Orgul, S. (1998). Optic nerve blood-flow abnormalities in glaucoma. Prog. Retinal Eye Res. 17, 267-289.
64. Flammer, J. and Mozaffarieh, M. (2007). What is the present pathogenetic concept of glaucomatous optic neuropathy? Surv. Ophthalmol. 52 Suppl 2, S162-S173.
65. Fortune, B., Bui, B.V., Cull, G., Wang, L., and Cioffi, G.A. (2004). Inter-ocular and inter-session reliability of the electroretinogram photopic negative response (PhNR) in non-human primates. Exp. Eye. Res. 78, 83-93.
66. Fraser, C.L. and Holder, G.E. (2011). Electroretinogram findings in unilateral optic neuritis. Doc. Ophthalmol. 123, 173-178.
67. Friedlander, M. (2012). Advances in treatment and management: Immunologic and cell-based regenerative therapies. Invest. Ophthalmol. Vis. Sci. 53, 2511-2514.
68. Frishman, L.J. (2006). Origins of the Electroretinogram. Principles and Practice of Clinical Electrophysiology of Vision. 2nd edn. J.R. Heckenlively and G.B. Arden, eds. (Cambridge, MA: MIT Press), pp. 139-183.
69. Frishman, L.J. and Sieving, P.A. (1995). Evidence for two sites of adaptation affecting the dark-adapted ERG of cats and primates. Vision Res. 35, 435-442.
70. Frishman, L.J., Reddy, M.G., and Robson, J.G. (1996a). Effects of background light on the human dark-adapted electroretinogram and psychophysical threshold. J. Opt. Soc. Am. A. 13, 601-612.
71. Frishman, L.J., Shen, F.F., Du, L., Robson, J.G., Harwerth, R.S., Smith, E.L. 3rd, Carter-Dawson, L., and Crawford, M.L. (1996b). The scotopic electroretinogram of macaque after retinal ganglion cell loss from experimental glaucoma. Invest. Ophthalmol. Vis. Sci. 37, 125-141.
72. Froehlich, J. and Kaufman, D.I. (1993). The pattern electroretinogram: N95 amplitudes in normal subjects and optic neuritis patients. Electroencephalogr. Clin. Neurophysiol. 88, 83-91.
73. Frohman, E.M., Racke, M.K., and Raine, C.S. (2006). Multiple sclerosis - the plaque and its pathogenesis. N. Eng. J. Med. 354, 942-955.
74. Gao, H., Qiao, X., Hefti, F., Hollyfield, J.G., and Knusel, B. (1997). Elevated mRNA expression of brain-derived neurotrophic factor in retinal ganglion cell layer after optic nerve injury. Invest. Ophthalmol. Vis. Sci. 38, 1840-1847.
75. Ghaffariyeh, A., Honarpisheh, N., Shakiba, Y., Puyan, S., Chamacham, T., Zahedi, F., and Zarrineghbal, M. (2009). Brain-derived neurotrophic factor in patients with normaltension glaucoma. Optometry 80, 635-638.
76. Ghezzi, A., Martinelli, V., Torri, V., Zaffaroni, M., Rodegher, M., Comi, G., Zibetti, A., and Canal, N. (1999). Long-term follow-up of isolated optic neuritis: The risk of developing multiple sclerosis, its outcome, and the prognostic role of paraclinical tests. J. Neurol. 246, 770-775.
77. Gills, J.P. (1966). Electroretinographic abnormalities and advanced multiple sclerosis. Invest. Ophthalmol. 5, 555-559.
78. Gold, R., Linington, C., and Lassmann, H. (2006). Understanding pathogenesis and therapy of multiple sclerosis via animal models: 70 years of merits and culprits in experimental autoimmune encephalomyelitis research. Brain 129 (Pt 8), 1953-1971.
79. Gotoh, Y., Machida, S., and Tazawa, Y. (2004). Selective loss of the photopic negative response in patients with optic nerve atrophy. Arch. Ophthalmol. 122, 341-346.
80. Green, D.R. (1998). Apoptotic pathways: The roads to ruin. Cell 94, 695-698.
81. Grozdanic, S.D. (2003). Laser-induced mouse model of chronic ocular hypertension. Invest. Ophthalmol. Vis. Sci. 44, 4337-4346.
82. Guazzo, E.P. (2005). A technique for producing demyelination of the rat optic nerves. J. Clin. Neurosci. 12, 54-58.
83. Guo, L., Salt, T.E., Maass, A., Luong, V., Moss, S.E., Fitzke, F.W., and Cordeiro, M.F. (2006). Assessment of neuroprotective effects of glutamate modulation on glaucoma-related retinal ganglion cell apoptosis in vivo. Invest. Ophthalmol. Vis. Sci. 47, 626- 633.
84. Guo, L., Normando, E.M., Nizari, S., Lara, D., and Cordeiro, M.F. (2010). Tracking longitudinal retinal changes in experimental ocular hypertension using the cSLO and spectral domain-OCT. Invest. Ophthalmol. Vis. Sci. 51, 6504-6513.
85. Guo, Y., Johnson, E.C., Cepurna, W.O., Dyck, J.A., Doser, T., and Morrison, J.C. (2011). Early gene expression changes in the retinal ganglion cell layer of a rat glaucoma model. Invest. Ophthalmol. Vis. Sci. 2011, 1460-1473.
86. Gupta, N. and Yucel, Y.H. (2007). Glaucoma as a neurodegenerative disease. Curr. Opin. Ophthalmol. 18, 110-114.
87. Gupta, N., Greenberg, G., de Tilly, L.N., Gray, B., Polemidiotis, M., and Yücel, Y.H. (2009). Atrophy of the lateral geniculate nucleus in human glaucoma detected by magnetic resonance imaging. Br. J. Ophthalmol. 93, 56-60.
88. Gupta, V.K., You, Y., Klistorner, A., and Graham, S.L. (2012a). Focus on molecules: Sphingosine 1 phosphate (S1P). Exp. Eye Res. 103, 119-120.
89. Gupta, A.A., Ding, D., Lee, R.K., Levy, R.B., and Bhattacharya, S.K. (2012b). Spontaneous ocular and neurologic deficits in transgenic mouse models of multiple sclerosis and noninvasive investigative modalities: A review. Invest. Ophthalmol. Vis. Sci. 53, 712-724.
90. Gupta, V.K., You, Y., Klistorner, A., and Graham, S.L. (2012c). Shp-2 regulates the TrkB receptor activity in the retinal ganglion cells under glaucomatous stress. Biochim. Biophys. Acta 1822, 1643-1649.
91. Gupta, V.K., You, Y., Li, J.C., Klistorner, A., and Graham, S.L. (2013). Protective effects of 7,8-dihydroxyflavone on retinal ganglion and RGC-5 cells against excitotoxic and oxidative stress. J. Mol. Neurosci. 49, 96-104.
92. Guy, J. (2000). New therapies for optic neuropathies: Development in experimental models. Curr. Opin. Ophthalmol. 11, 421-429.
93. Hall, S.M. (1972). The effect of injections of lysophosphatidyl choline into white matter of the adult mouse spinal cord. J. Cell. Sci. 10, 535-546.
94. Halliday, A.M., McDonald, W.I., and Mushin, J. (1972). Delayed visual evoked response in optic neuritis. Lancet i, 982-985.
95. Harada, C., Namekata, K., Guo, X., Yoshida, H., Mitamura, Y., Matsumoto, Y., Tanaka, K., Ichijo, H., and Harada, T. (2010). ASK1 deficiency attenuates neural cell death in GLAST-deficient mice, a model of normal tension glaucoma. Cell Death Differ. 17, 1751-1759.
96. Hardy, J. and Revesz, T. (2012). The spread of neurodegenerative disease. N. Engl. J. Med. 366, 2126-2128.
97. Hasegawa, Y., Suzuki, H., Sozen, T., Rolland, W., and Zhang, J.H. (2010). Activation of sphingosine 1-phosphate receptor-1 by FTY720 is neuroprotective after ischemic stroke in rats. Stroke 41, 368-374.
98. Hayreh, S.S. (1981). Experimental allergic encephalomyelitis. II. Retinal and other ocular manifestations. Invest. Ophthalmol. Vis. Sci. 21, 270-281.
99. Hayreh, S.S. (2000). Steroid therapy for visual loss in patients with giant-cell arteritis. Lancet 355, 1572-1573.
100. Hayreh, S.S. (2008). Animal model for nonarteritic anterior ischemic optic neuropathy. J. Neuroophthalmol. 28, 79-80.
101. Hayreh, S.S. (2009). Ischemic optic neuropathy. Prog. Retin. Eye. Res. 28, 34-62.
102. Hayreh, S.S., Massanari, R.M., Yamada, T., and Hayreh, S.M. (1981). Experimental allergic encephalomyelitis. I. Optic nerve and central nervous system manifestations. Invest. Ophthalmol. Vis. Sci. 21, 256-269.
103. Hofbauer, A. and Drager, U.C. (1985). Depth segregation of retinal ganglion cells projecting to mouse superior colliculus. J. Comp. Neurol. 234, 465-474.
104. Holcombe, D.J., Lengefeld, N., Gole, G.A., and Barnett, N.L. (2008). Selective inner retinal dysfunction precedes ganglion cell loss in a mouse glaucoma model. Br. J. Ophthalmol. 92, 683-688.
105. Holder, G.E., Brigell, M.G., Hawlina, M., Meigen. T., Vaegan, B.M.; International Society for Clinical Electrophysiology of Vision. (2007). ISCEV standard for clinical pattern electroretinography - 2007 update. Doc. Ophthalmol. 114, 111-116.
106. Holder, G.E., Gale, R.P., Acheson, J.F., and Robson, A.G. (2009). Electrodiagnostic assessment in optic nerve disease. Curr. Opin. Neurol. 22, 3-10.
107. Hu, B., Yip, H.K., and So, K.F. (1998). Localization of p75 neurotrophin receptor in the retina of the adult SD rat: An immunocytochemical study at light and electron microscopic levels. Glia 24, 187-197.
108. Hu, Y., Cho, S., and Goldberg, J.L. (2010). Neurotrophic effect of a novel TrkB agonist on retinal ganglion cells. Invest. Ophthalmol. Vis. Sci. 51, 1747-1754.
109. Huang, W., Fileta, J.B., Dobberfuhl, A., Filippopolous, T., Guo, Y., Kwon, G., and Grosskreutz, C.L. (2005a). Calcineurin cleavage is triggered by elevated intraocular pressure, and calcineurin inhibition blocks retinal ganglion cell death in experimental glaucoma. Proc. Natl. Acad. Sci. USA 102, 12242-12247.
110. Huang, W., Dobberfuhl, A., Filippopoulos, T., Ingelsson, M., Fileta, J.B., Poulin, N.R., and Grosskreutz, C.L. (2005b). Transcriptional up-regulation and activation of initiating caspases in experimental glaucoma. Am. J. Pathol. 167, 673-681.
111. Isenmann, S. (2003). Molecular determinants of retinal ganglion cell development, survival, and regeneration. Prog. Retinal Eye Res. 22, 483-543.
112. Jang, S.W., Liu, X., Yepes, M., Shepherd, K.R., Miller, G.W., Liu, Y., Wilson, W.D., Xiao, G., Blanchi, B., Sun, Y.E., et al. (2010). A selective TrkB agonist with potent neurotrophic activities by 7,8-dihydroxyflavone. Proc. Natl. Acad. Sci. USA 107, 2687-2692.
113. Jeffery, G. and Erskine, L. (2005). Variations in the architecture and development of the vertebrate optic chiasm. Prog. Retin. Eye Res. 24, 721-753.
114. Ji, J.Z., Elyaman, W., Yip, H.K., Lee, V.W., Yick, L.W., Hugon, J., and So, K.F. (2004). CNTF promotes survival of retinal ganglion cells after induction of ocular hypertension in rats: The possible involvement of STAT3 pathway. Eur. J. Neurosci. 19, 265-272.
115. Johnson, T.V. and Tomarev, S.I. (2010). Rodent models of glaucoma. Brain Res. Bull. 81, 349-358.
116. Jonas, J.B. (2011). Role of cerebrospinal fluid pressure in the pathogenesis of glaucoma. Acta Ophthalmol. 89, 505-514.
117. Jones, S. (2005). Electrophysiological Correlates of Relapse, Remission, Persistent Sensorimotor Deficit, and Long-term Recovery Processes in Multiple Sclerosis. Multiple Sclerosis as a Neuronal Disease. S.G. Waxman, ed. (Burlington, MA: Elsevier Academic Press), pp. 227-239.
118. Kase, S., Yoshida, K., Suzuki, S., Ohshima, K., Ohno, S., and Ishida, S. (2011). Diffuse infiltrating retinoblastoma invading subarachnoid space. Clin. Ophthalmol. 5, 861-863.
119. Kaufman, D.I., Trobe, J.D., Eggenberger, E.R., and Whitaker, J.N. (2000). Practice parameter: The role of corticosteroids in the management of acute monosymptomatic optic neuritis. Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 54, 2039-2044.
120. Kermer, P., Klöcker, N., Labes, M., and Bähr, M. (1998). Inhibition of CPP32-like proteases rescues axotomized retinal ganglion cells from secondary cell death in vivo. J. Neurosci. 18, 4656-4662.
121. Kermer, P., Ankerhold, R., Klöcker, N., Krajewski, S., Reed, J.C., and Bähr, M. (2000). Caspase-9: Involvement in secondary death of axotomized rat retinal ganglion cells in vivo. Mol. Brain. Res. 85, 144-150.
122. Kiernan, J.A. and Hudson, A.J. (1991). Changes in size of cortical and lower motor neurons in amyotrophic lateral sclerosis. Brain 114, 843-853.
123. Kim, T.W., Kang, K.B., Choung, H.-K., Park, K.H., and Kim, D.M. (2000). Elevated glutamate levels in the vitreous body of an in vivo model of optic nerve ischemia. Arch. Ophthalmol. 118, 533-536.
124. Klistorner, A., Graham, S.L., Martins, A., Grigg, J.R., Arvind, H., Kumar, R.S., James, A.C., and Billson, F.A. (2007a). Multifocal blue-on-yellow visual evoked potentials in early glaucoma. Ophthalmology 114, 1613-1621.
125. Klistorner, A., Graham, S., Fraser, C., Garrick, R., Nguyen, T., Paine, M., O'Day, J., Grigg, J., Arvind, H., and Billson, F.A. (2007b). Electrophysiological evidence for heterogeneity of lesions in optic neuritis. Invest. Ophthalmol. Vis. Sci. 48, 4549-4556.
126. Klistorner, A., Arvind, H., Nguyen, T., Garrick, R., Paine, M., Graham, S., O'Day, J., Grigg, J., Billson, F., and Yiannikas, C. (2008). Axonal loss and myelin in early ON loss in postacute optic neuritis. Ann. Neurol. 64, 325-331.
127. Klocker, N. and Kermer, P. (2000). Brain-derived neurotrophic factor-mediated neuroprotection of adult rat retinal ganglion cells in vivo does not exclusively depend on phosphatidylinositol- 3'-kinase:protein kinase B signaling. J. Neurosci. 20, 6962-6967.
128. Kohzaki, K., Vingrys, A.J., and Bui, B.V. (2008). Early inner retinal dysfunction in streptozotocin-induced diabetic rats. Invest. Ophthalmol. Vis. Sci. 49, 3595-3604.
129. Kornek, B., Storch, M.K., Weissert, R., Wallstroem, E., Stefferl, A., Olsson, T., Linington, C., Schmidbauer, M., and Lassmann, H. (2000). Multiple sclerosis and chronic autoimmune encephalomyelitis: A comparative quantitative study of axonal injury in active, inactive, and remyelinated lesions. Am. J. Pathol. 157, 267-276.
130. Kuhlmann, T., Lingfeld, G., Bitsch, A., Schuchardt, J., and Brück, W. (2002). Acute axonal damage in multiple sclerosis is most extensive in early disease stages and decreases over time. Brain 125, 2202-2212.
131. Kumamaru, E., Numakawa, T., Adachi, N., and Kunugi, H. (2011). Glucocorticoid suppresses BDNF-stimulated MAPK/ERK pathway via inhibiting interaction of Shp2 with TrkB. FEBS Lett. 585, 3224-3228.
132. Kwon, Y.H., Fingert, J.H., Kuehn, M.H., and Alward, W.L.M. (2009). Primary open-angle glaucoma. N. Engl. J. Med. 360, 1113-1124.
133. Lachapelle, F., Bachelin, C., Moissonnier, P., Nait-Oumesmar, B., Hidalgo, A., Fontaine, D., and Baron-Van Evercooren, A. (2005). Failure of remyelination in the nonhuman primate optic nerve. Brain Pathol. 15, 198-207.
134. Lassmann, H. (2005). Pathology of Neurons in Multiple Sclerosis. Multiple Sclerosis as a Neuronal Disease. S.G. Waxman, ed. (Amsterdam: Elsevier), pp. 153-164.
135. Lau, C., Zhang, J.W., Xing, K.K., Zhou, I.Y., Cheung, M.M., Chan, K.C., and Wu, E.X. (2011). BOLD responses in the superior colliculus and lateral geniculate nucleus of the rat viewing an apparent motion stimulus. Neuroimage 58, 878-884.
136. Leamey, C.A., Protti, D.A., and Dreher, B. (2008). Comparative Survey of the Mammalian Visual System with Reference to the Mouse. Eye, Retina, and Visual System of the Mouse. L. M. Chalupa and R. W. Williams, eds. (MIT Press), pp. 35-60.
137. Lebrun-Julien, F., Morquette, B., Douillette, A., Saragovi, H.U., and Di Polo, A. (2009). Inhibition of p75(NTR) in glia potentiates TrkA-mediated survival of injured retinal ganglion cells. Mol. Cell. Neurosci. 40, 410-420.
138. Lebrun-Julien, F., Bertrand, M.J., De Backer, O., Stellwagen, D., Morales, C.R., Di Polo, A., and Barker, P.A. (2010). ProNGF induces TNFalpha-dependent death of retinal ganglion cells through a p75NTR non-cell-autonomous signaling pathway. Proc. Natl. Acad. Sci. USA 107, 3817-3822.
139. Levin, L.A. (2007). Axonal loss and neuroprotection in optic neuropathies. Can. J. Ophthalmol. 42, 403-408.
140. Libby, R.T., Li, Y., Savinova, O.V., Barter, J., Smith, R.S., Nickells, R.W., and John, S.W. (2005). Susceptibility to neurodegeneration in a glaucoma is modified by Bax gene dosage. PLoS Genet. 1, 17-26.
141. Limb, G.A. and Martin, K.R. (2011). Current prospects in optic nerve protection and regeneration: Sixth ARVO/Pfizer Ophthalmics Research Institute conference. Invest. Ophthalmol. Vis. Sci. 52, 5941-5954.
142. Lindsey, J.D. and Weinreb, R.N. (2005). Elevated intraocular pressure and transgenic applications in the mouse. J. Glaucoma 14, 318-320.
143. Lipton, S.A. (2003). Possible role for memantine in protecting retinal ganglion cells from glaucomatous damage. Surv. Ophthalmol. 48 Suppl 1, S38-S46.
144. Liu, M., Duggan, J., Salt, T.E., and Cordeiro, M.F. (2011). Dendritic changes in visual pathways in glaucoma and other neurodegenerative conditions. Exp. Eye Res. 92, 244-250.
145. Liu, L., Drouet, V., Wu, J.W., Witter, M.P., Small, S.A., Clelland, C., and Duff, K. (2012). Trans-synaptic spread of tau pathology in vivo. PLoS ONE 7, e31302.
146. Lucchinetti, C.F., Popescu, B.F.G., Bunyan, R.F., Moll, N.M., Roemer, M.D., Lassmann, H., Brück, W., Parisi, J.E., Scheithauer, B.W., Giannini, C., et al. (2011). Inflammatory cortical demyelination in early multiple sclerosis. N. Eng. J. Med. 365, 2188-2197.
147. Madill, S.A. and Riordan-Eva, P. (2004). Disorders of the anterior visual pathways. J. Neurol. Neurosurg. Psychiatry 75 Suppl 4, iv12-iv19.
148. Magoon, E.H. and Robb, R.M. (1981). Development of myelin in human optic nerve and tract. A light and electron microscopic study. Arch. Ophthalmol. 99, 655-659.
149. Maier, K., Rau, C.R., Storch, M.K., Sättler, M.B., Demmer, I., Weissert, R., Taheri, N., Kuhnert, A.V., Bähr, M., and Diem, R. (2004). Ciliary neurotrophic factor protects retinal ganglion cells from secondary cell death during acute autoimmune optic neuritis in rats. Brain Pathol. 14, 378-387.
150. Malik, J.M., Shevtsova, Z., Bähr, M., and Kügler, S. (2005). Long-term in vivo inhibition of CNS neurodegeneration by Bcl-XL gene transfer. Mol. Ther. 11, 373-381.
151. Marcic, T.S., Belyea, D.A., and Katz, B. (2003). Neuroprotection in glaucoma: A model for neuroprotection in optic neuropathies. Curr. Opin. Ophthalmol. 14, 353-356.
152. Marmor, M.F., Fulton, A.B., Holder, G.E., Miyake, Y., Brigell, M., Bach, M.; International Society for Clinical Electrophysiology of Vision. (2009). ISCEV Standard for full-field clinical electroretinography (2008 update). Doc. Ophthalmol. 118, 69-77.
153. Martin, K.R.G. (2003). Gene therapy with brain-derived neurotrophic factor as a protection: Retinal ganglion cells in a rat glaucoma model. Invest. Ophthalmol. Vis. Sci. 44, 4357-4365.
154. Martin, K.R. and Quigley, H.A. (2004). Gene therapy for optic nerve disease. Eye (Lond). 18, 1049-1055.
155. Mattson, M.P. (2007). Calcium and neurodegeneration. Aging Cell 6, 337-350.
156. McKernan, D.P. and Cotter, T.G. (2007). A critical role for Bim in retinal ganglion cell death. J. Neurochem. 102, 922-930.
157. McKinnon, S. J., Schlamp, C. L., and Nickells, R. W. (2009). Mouse models of retinal ganglion cell death and glaucoma. Exp. Eye Res. 88, 816-824.
158. Meyer, R., Weissert, R., Diem, R., Storch, M.K., de Graaf, K.L., Kramer, B., and Bahr, M. (2001). Acute neuronal apoptosis in a rat model of multiple sclerosis. J. Neurosci. 21, 6214-6220.
159. Midorikawa, R., Takei, Y., and Hirokawa, N. (2006). KIF4 motor regulates activity-dependent neuronal survival by suppressing PARP-1 enzymatic activity. Cell 125, 371-383.
160. Milea, D., Amati-Bonneau, P., Reynier, P., and Bonneau, D. (2010). Genetically determined optic neuropathies. Curr. Opin. Neurol. 23, 24-28.
161. Minichiello, L. (2009). TrkB signalling pathways in LTP and learning. Nat. Rev. Neurosci. 10, 850-860.
162. Miyake, K., Yoshida, M., Inoue, Y., and Hata, Y. (2007). Neuroprotective effect of transcorneal electrical stimulation on the acute phase of optic nerve injury. Invest. Ophthalmol. Vis. Sci. 48, 2356-23561.
163. Morimoto, T., Miyoshi, T., Fujikado, T., Tano, Y., and Fukuda, Y. (2002). Electrical stimulation enhances the survival of axotomized retinal ganglion cells in vivo. Neuroreport 13, 227-230.
164. Morin, L.P. (1994). The circadian visual system. Brain Res. Rev. 67, 102-127.
165. Morrison, J.C., Moore, C.G., Deppmeier, L.M., Gold, B.G., Meshul, C.K., and Johnson, E.C. (1997). A rat model of chronic pressure-induced optic nerve damage. Exp. Eye Res. 64, 85-96.
166. Morrison, J.C., Johnson, E.C., Cepurna, W.O., and Funk, R.H. (1999). Microvasculature of the rat optic nerve head. Invest. Ophthalmol. Vis. Sci. 40, 1702-1709.
167. Morrison, J.C., Cepurna Ying Guo, W.O., and Johnson, E.C. (2011). Pathophysiology of human glaucomatous optic nerve damage: Insights from rodent models of glaucoma. Exp. Eye Res. 93, 156-164.
168. Moschovakis, A.K. (1996). The superior colliculus and eye movement control. Curr. Opin. Neurobiol. 6, 811-816.
169. Mozafari, S., Sherafat, M.A., Javan, M., Mirnajafi-Zadeh, J., and Tiraihi, T. (2010). Visual evoked potentials and MBP gene expression imply endogenous myelin repair in adult rat optic nerve and chiasm following local lysolecithin induced demyelination. Brain Res. 1351, 50-56.
170. Mozafari, S., Javan, M., Sherafat, M.A., Mirnajafi-Zadeh, J., Heibatollahi, M., Pour-Beiranvand, S., Tiraihi, T., and Ahmadiani, A. (2011). Analysis of structural and molecular events associated with adult rat optic chiasm and nerves demyelination and remyelination: Possible role for 3rd ventricle proliferating cells. Neuromol. Med. 13, 138-150.
171. Naarendorp, F., Sato, Y., Cajdric, A., and Hubbard, N.P. (2001). Absolute and relative sensitivity of the scotopic system of rat: Electroretinography and behavior. Vis. Neurosci. 18, 641-656.
172. Nadkarni, N. and Lisak, R.P. (1993). Guillain-Barrésyndrome (GBS) with bilateral optic neuritis and central white matter disease. Neurology 43, 842-843.
173. Nakazawa, T., Nakazawa, C., Matsubara, A., Noda, K., Hisatomi, T., She, H., Michaud, N., Hafezi-Moghadam, A., Miller, J.W., and Benowitz, L.I. (2006). Tumor necrosis factor-alpha mediates oligodendrocyte death and delayed retinal
174. Neel, B.G., Gu, H., and Pao, L. (2003). The'Shp'ing news: SH2 domain-containing tyrosine phosphatases in cell signaling. Trends Biochem. Sci. 28, 284-293.
175. Neufeld, A.H., Das, S., Vora, S., Gachie, E., Kawai, S., Manning, P.T., and Connor, J.R. (2002). A prodrug of a selective inhibitor of inducible nitric oxide synthase is neuroprotective in the rat model of glaucoma. J. Glaucoma 11, 221-225.
176. Newman, N.J. (1996). Optic neuropathy. Neurology 46, 315-322.
177. Niemeyer, G. (2005). ERG components of negative polarity from the inner retina and the optic nerve response. Doc. Ophthalmol. 111, 179-189.
178. O'Neill, E.C., Mackey, D.A., Connell, P.P., Hewitt, A.W., Danesh-Meyer, H.V., and Crowston, J.G. (2009). The optic nerve head in hereditary optic neuropathies. Nat. Rev. Neurol. 5, 277-287.
179. O'Neill, E.C., Danesh-Meyer, H.V., Connell, P.P., Trounce, I.A., Coote, M.A., Mackey, D.A., and Crowston, J.G. (2010). The optic nerve head in acquired optic neuropathies. Nat. Rev. Neurol. 6, 221-236.
180. Odom, J.V., Bach, M., Brigell, M., Holder, G.E., McCulloch, D.L., Tormene, A.P., and Vaegan. (2010). ISCEV standard for clinical visual evoked potentials (2009 update). Doc. Ophthalmol. 120, 111-119.
181. Ohlmann, A. and Tamm, E.R. (2012). Norrin: Molecular and functional properties of an angiogenic and neuroprotective growth factor. Prog. Retin. Eye Res. 31, 243-257.
182. Pacelli, R., Cella, L., Conson, M., Tranfa, F., Strianese, D., Liuzzi, R., Solla, R., Farella, A., Salvatore, M., and Bonavolonta, G. (2011). Fractionated stereotactic radiation therapy for orbital optic nerve sheath meningioma - a single institution experience and a short review of the literature. J. Radiat. Res. 52, 82-87.
183. Peachey, N.S. and Ball, S.L. (2003). Electrophysiological analysis of visual function in mutant mice. Doc. Ophthalmol. 107, 13-36.
184. Pease, M.E., McKinnon, S.J., Quigley, H.A., Kerrigan-Baumrind, L.A., and Zack, D.J. (2000). Obstructed axonal transport of BDNF and its receptor TrkB in experimental glaucoma. Invest. Ophthalmol. Vis. Sci. 41, 764-774.
185. Pelletier, D. and Hafler, D.A. (2012). Fingolimod for multiple sclerosis. N. Eng. J. Med. 366, 339-347.
186. Pernet, V., Bourgeois, P., and Di Polo, A. (2007). A role for polyamines in retinal ganglion cell excitotoxic death. J. Neurochem. 103, 1481-1490.
187. Peterson, J., Kidd, D., and Trapp, B.D. (2005). Axonal degeneration in multiple sclerosis: The histopathological evidence. Multiple Sclerosis as a Neuronal Disease, S.G. Waxman, ed. (Amsterdam: Elsevier), pp. 165-184.
188. Planchamp, V., Bermel, C., Tönges, L., Ostendorf, T., Kügler, S., Reed, J.C., Kermer, P., Bähr, M., and Lingor, P. (2008). BAG1 promotes axonal outgrowth and regeneration in vivo via Raf-1 and reduction of ROCK activity. Brain 131 (Pt 10), 2606-2619.
189. Purves, D. (2001). Central visual pathways. Neuroscience 2nd edn. D. Purves, et al., eds. (Sunderland, MA: Sinauer Associates).
190. Qi, X., Sun, L., Lewin, A.S., Hauswirth, W.W., and Guy, J. (2007). The mutant human ND4 subunit of complex I induces optic neuropathy in the mouse. Invest. Ophthalmol. Vis. Sci. 48, 1-10.
191. Qiu, W., Wei, R., Zhang, C., Zhang, C., Leng, W., and Wang, W. (2010). A glycine site-specific NMDA receptor antagonist protects retina ganglion cells from ischemic injury by modulating apoptotic cascades. J. Cell. Physiol. 223, 819-826.
192. Qu, J., Wang, D., and Grosskreutz, C.L. (2010). Mechanisms of retinal ganglion cell injury and defense in glaucoma. Exp. Eye Res. 91, 48-53.
193. Quigley, H.A. and Broman, A.T. (2006). The number of people with glaucoma worldwide in 2010 and 2020. Br. J. Ophthalmol. 90, 262-267.
194. Rangaswamy, N.V., Frishman, L.J., Dorotheo, E.U., Schiffman, J.S., Bahrani, H.M., and Tang, R.A. (2004). Photopic ERGs in patients with optic neuropathies: Comparison with primate ERGs after pharmacologic blockade of inner retina. Invest. Ophthalmol. Vis. Sci. 45, 3827-3837.
195. Rangaswamy, N.V., Zhou, W., Harwerth, R.S., and Frishman, L.J. (2006). Effect of experimental glaucoma in primates on oscillatory potentials of the slow-sequence mfERG. Invest. Ophthalmol. Vis. Sci. 47, 753-767.
196. Ren, R., Jonas, J.B., Tian, G., Zhen, Y., Ma, K., Li, S., Wang, H., Li, B., Zhang, X., and Wang, N. (2010). Cerebrospinal fluid pressure in glaucoma: A prospective study. Ophthalmol. 117, 259-266.
197. Ren, R., Li, Y., Liu, Z., Liu, K., and He, S. (2012). Long-term rescue of rat retinal ganglion cells and visual function by AAV-mediated BDNF expression after acute elevation of intraocular pressure. Invest. Ophthalmol. Vis. Sci. 53, 1003-10011.
198. Riordan-Eva, P. (2004). Anatomy & Embryology of the Eye. Vaughan & Asbury's General Ophthalmology 16th edn. P. Riordan-Eva and J.P. Whitcher, eds. (Columbus, OH: McGraw-Hill), pp. 1- 28.
199. Riordan-Eva, P. and Hoyt, W.F. (2004). Neuro-ophthalmology. Vaughan & Asbury's General Ophthalmology 16th edn. P. Riordan-Eva and J.P. Whitcher, eds. (Columbus, OH: McGraw-Hill), pp. 261-306.
200. Russo, R., Cavaliere, F., Rombolà, L., Gliozzi, M., Cerulli, A., Nucci, C., Fazzi, E., Bagetta, G., Corasaniti, M.T., and Morrone, L.A. (2008a). Rational basis for the development of coenzyme as a neurotherapeutic agent for retinal protection. Prog. Brain Res. 173, 575-582.
201. Russo, R., Cavaliere, F., Berliocchi, L., Nucci, C., Gliozzi, M., Mazzei, C., Tassorelli, C., Corasaniti, M.T., Rotiroti, D., Bagetta, G., et al. (2008b). Modulation of pro-survival and death-associated pathways under retinal ischemia/reperfusion: Effects of NMDA receptor blockade. J. Neurochem. 107, 1347-1357.
202. Salgado, C., Vilson, F., Miller, N.R., and Bernstein, S.L. (2011). Cellular inflammation in nonarteritic anterior ischemic optic neuropathy and its primate model. Arch. Ophthalmol. 129, 1583-1591.
203. Samsel, P.A., Kisiswa, L., Erichsen, J.T., Cross, S.D., and Morgan, J.E. (2011). A novel method for the induction of experimental glaucoma using magnetic microspheres. Invest. Ophthalmol. Vis. Sci. 52, 1671-1675.
204. Sappington, R.M., Carlson, B.J., Crish, S.D., and Calkins, D.J. (2010). The microbead occlusion model: A paradigm for induced ocular hypertension in rats and mice. Invest. Ophthalmol. Vis. Sci. 51, 207-216.
205. Saszik, S.M., Robson, J.G., and Frishman, L.J. (2002). The scotopic threshold response of the dark-adapted electroretinogram of the mouse. J. Physiol. 543 (Pt 3), 899-916.
206. Scherer, S. (1999). Axonal pathology in demyelinating diseases. Ann. Neurol. 45, 6-7.
207. Schlieve, C.R., Tam, A., Nilsson, B.L., Lieven, C.J., Raines, R.T., and Levin, L.A. (2006). Synthesis and characterization of a novel class of reducing agents that are highly neuroprotective for retinal ganglion cells. Exp. Eye Res. 83, 1252-1259.
208. Schrier, S.A. and Falk, M.J. (2011). Mitochondrial disorders and the eye. Curr. Opin. Ophthalmol. 22, 325-331.
209. Schwartz, M. and Yoles, E. (2000). Neuroprotection: A new treatment modality for glaucoma? Curr. Opin. Ophthalmol. 11, 107-111.
210. Scolding, N.J. and Franklin, R. (1998). Axon loss in multiple sclerosis. Lancet 352, 340-341.
211. Sefton, A.J. and Dreher, B. (2004). Visual system. The Rat Nervous System 3rd edn. G. Paxinos, ed. (San Diego: Elsevier), pp. 1082-1165.
212. Shareef, S.R., Garcia-Valenzuela, E., Salierno, A., Walsh, J., and Sharma, S.C. (1995). Chronic ocular hypertension following episcleral venous occlusion in rats. Exp. Eye Res. 61, 379-382.
213. Shibata, K., Shibagaki, Y., Nagai, C., and Iwata, M. (1999). Visual evoked potentials and electroretinograms in an early stage of Leber's hereditary optic neuropathy. J. Neurol. 246, 847-849.
214. Sieving, P.A. and Nino, C. (1988). Scotopic threshold response (STR) of the human electroretinogram. Invest. Ophthalmol. Vis. Sci. 29, 1608-1614.
215. Smith, K.J. and Waxman, S.G. (2005). The conduction properties of demyelinated and remyelinated axons. Multiple Sclerosis as a Neuronal Disease. S.G. Waxman, ed. (Burlington, MA: Elsevier Academic Press), pp. 85-100.
216. Su, J.H., Deng, G., and Cotman, C.W. (1997). Transneuronal degeneration in the spread of Alzheimer's disease pathology: Immunohistochemical evidence for the transmission of tau hyperphosphorylation. Neurobiol. Dis. 4, 365-375.
217. Sugiyama, K., Gu, Z.-B., Kawase, C., Yamamoto, T., and Kitazawa, Y. (1999). Optic nerve and peripapillary choroidal microvasculature of the rat eye. Invest. Ophthalmol. Vis. Sci. 40, 3084-3090.
218. Sun, H., Wang, Y., Pang, I.-H., Shen, J., Tang, X., Li, Y., Liu, C., and Li, B. (2011). Protective effect of a JNK inhibitor against retinal ganglion cell loss induced by acute moderate ocular hypertension. Mol. Vis. 17, 864-875.
219. Takeuchi, N., Horikoshi, T., Kinouchi, H., Watanabe, A., Yagi, T., Mitsuka, K., and Senbokuya, N. (2012). Diagnostic value of the optic nerve sheath subarachnoid space in patients with intracranial hypotension syndrome. J. Neurosurg. 117, 372-377.
220. Takihara, Y., Inatani, M., Hayashi, H., Adachi, N., Iwao, K., Inoue, T., Iwao, M., and Tanihara, H. (2011). Dynamic imaging of axonal transport in living retinal ganglion cells in vitro. Invest. Ophthalmol. Vis. Sci. 52, 3039-3045.
221. Tezel, G. and Wax, M.B. (2000). Increased production of tumor necrosis factor-alpha by glial cells exposed to simulated ischemia or elevated hydrostatic pressure induces apoptosis in cocultured retinal ganglion cells. J. Neurosci. 20, 8693-8700.
222. Tezel, G., Yang, X., Yang, J., and Wax, M.B. (2004). Role of tumor necrosis factor receptor-1 in the death of retinal ganglion cells following optic nerve crush injury in mice. Brain Res. 996, 202-212.
223. Trapp, B.D., Peterson, J., and Ransohoff, R.M. (1998). Axonal transection in the lesions of multiple sclerosis. N. Eng. J. Med. 338, 278-285.
224. Trick, G.L. (2006). The Pattern Electroretinogram in Glaucoma and Ocular Hypertension. Principles and Practice of Clinical Electrophysiology of Vision. 2nd edn. J.R. Heckenlively and G.B. Arden, eds. (Cambridge, MA: MIT Press), pp. 851.
225. Uchibayashi, R., Tsuruma, K., Inokuchi, Y., Shimazawa, M., and Hara, H. (2011). Involvement of Bid and caspase-2 in endoplasmic reticulum stress- and oxidative stress-induced retinal ganglion cell death. J. Neurosci. Res. 89, 1783-1794.
226. Urcola, J.H., Hernandez, M., and Vecino, E. (2006). Three experimental glaucoma models in rats: Comparison of the effects of intraocular pressure elevation on retinal ganglion cell size and death. Exp. Eye Res. 83, 429-437.
227. Van Bergen, N.J., Wood, J.P.M., Chidlow, G., Trounce, I.A., Casson, R.J., Ju, W.-K., Weinreb, R.N., and Crowston, J.G. (2009). Recharacterization of the RGC-5 retinal ganglion cell line. Invest. Ophthalmol. Vis. Sci. 50, 4267-4272.
228. Vidal-Sanz, M., Salinas-Navarro, M., Nadal-Nicolás, F.M., Alarcón-Martínez, L., Valiente-Soriano, F.J., de Imperial, J.M., Avilés-Trigueros, M., Agudo-Barriuso, M., and Villegas-Pérez, M.P. (2012). Understanding glaucomatous damage: Anatomical and functional data from ocular hypertensive rodent retinas. Prog. Retinal Eye Res. 31, 1-27.
229. Vila, M. and Przedborski, S. (2003). Targeting programmed cell death in neurodegenerative diseases. Nat. Rev. Neurosci. 4, 365-375.
230. Viswanathan, S., Frishman, L.J., Robson, J.G., Harwerth, R.S., and Smith III, E.L. (1999). The photopic negative response of the macaque electroretinogram: Reduction by experimental glaucoma. Invest. Ophthalmol. Vis. Sci. 40, 1124-1136.
231. Viswanathan, S., Frishman, L.J., and Robson, J.G. (2000). The uniform field and pattern ERG in macaques with experimental glaucoma: Removal of spiking activity. Invest. Ophthalmol. Vis. Sci. 41, 2797-2810.
232. Viswanathan, S., Frishman, L.J., Robson, J.G., and Walters, J.W. (2001). The photopic negative response of the flash electroretinogram in primary open angle glaucoma. Invest. Ophthalmol. Vis. Sci. 42, 514-522.
233. Wang, J.T., Medress, Z.A., and Barres, B.A. (2012). Axon degeneration: Molecular mechanisms of a self-destruction pathway. J. Cell. Biol. 196, 7-18.
234. Watanabe, M. and Fukuda, Y. (2002). Survival and axonal regeneration of retinal ganglion cells in adult cats. Prog. Retin. Eye Res. 21, 529-553.
235. You, Y., Klistorner, A., Thie, J., and Graham, S.L. (2011a). Latency delay of visual evoked potential is a real measurement of demyelination in a rat model of optic neuritis. Invest. Ophthalmol. Vis. Sci. 52, 6911-6918.
236. You, Y., Klistorner, A., Thie, J., and Graham, S.L. (2011b). Improving reproducibility of VEP recording in rats: Electrodes, stimulus source and peak analysis. Doc. Ophthalmol. 123, 109-119.
237. You, Y., Klistorner, A., Thie, J., Gupta, V.K., and Graham, S.L. (2012a). Axonal loss in a rat model of optic neuritis is closely correlated with visual evoked potential amplitudes using electroencephalogram based scaling. Invest. Ophthalmol. Vis. Sci. 53, 3662.
238. You, Y., Thie, J., Klistorner, A., Gupta, V.K., and Graham, S.L. (2012b). Normalization of visual evoked potentials using underlying electroencephalogram levels improves amplitude reproducibility in rats. Invest. Ophthalmol. Vis. Sci. 53, 1473-1478.
239. You, Y., Gupta, V.K., Graham, S.L., and Klistorner, A. (2012c). Anterograde degeneration along the visual pathway after optic nerve injury. PLoS ONE 7, e52061.
240. Youl, B.D., Turano, G., Miller, D.H., Towell, A.D., MacManus, D.G., Moore, S.G., Jones, S.J., Barrett, G., Kendall, B.E., Moseley, I.F., et al. (1991). The pathophysiology of acute optic neuritis: An association of gadolinium leakage with clinical and electrophysiological deficits. Brain 114, 2437-2450.
241. Youle, R.J. and Strasser, A. (2008). The BCL-2 protein family: Opposing activities that mediate cell death. Nat. Rev. Mol. Cell. Biol. 9, 47-59.
242. Yu, H., Koilkonda, R.D., Chou, T.H., Porciatti, V., Ozdemir, S.S., Chiodo, V., Boye, S.L., Boye, S.E., Hauswirth, W.W., Lewin, A.S., et al. (2012). Gene delivery to mitochondria by targeting modified adenoassociated virus suppresses Leber's hereditary optic neuropathy in a mouse model. Proc. Natl. Acad. Sci. USA 109, E1238-E1247.
243. Yu-Wai-Man, P., Griffiths, P.G., and Chinnery, P.F. (2011). Mitochondrial optic neuropathies - disease mechanisms and therapeutic strategies. Prog. Retin. Eye Res. 30, 81-114.
244. Yücel, Y. (2003). Effects of retinal ganglion cell loss on magno-, parvo-, koniocellular pathways in the lateral geniculate nucleus and visual cortex in glaucoma. Prog. Retin. Eye Res. 22, 465-481.
245. Zanna, C., Ghelli, A., Porcelli, A.M., Martinuzzi, A., Carelli, V., and Rugolo, M. (2005). Caspase-independent death of Leber's hereditary optic neuropathy cybrids is driven by energetic failure and mediated by AIF and endonuclease G. Apoptosis 10, 997-1007.
246. Zhang, J., Rubin, R.M., and Rao, N.A. (2007). Anatomy and Embryology of the Optic Nerve. Duane's Foundations of Clinical Ophthalmology. W. Tasman and E.A. Jaeger, eds. (Philadelphia, PA: Lippincott Williams & Wilkins).
247. Zhu, B., Wayne Moore, G.R., Zwimpfer, T.J., Kastrukoff, L.F., Dyer, J.K., Steeves, J.D., Paty, D.W., and Cynader, M.S. (1999). Axonal cytoskeleton changes in experimental optic neuritis. Brain Res. 824, 204-217.